HANGZHOU BIO-SINCERITY PHARMA-TECH CO.,LTD.

Andere Sprachen Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.

Aktien

301096

CNE1000056N5

301096

Biotechnologie

Schlusskurs Shenzhen S.E. Andere Börsenplätze 16.07.2025			% 5 Tage	% 1. Jan.
49,13 ^CNY	+0,22 %		+8,55 %	+29,49 %

22.04.	Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. gibt Ergebnisse für das erste Quartal zum 31. März 2025 bekannt	CI
22.04.	Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. gibt Ergebnisse für das gesamte Geschäftsjahr zum 31. Dezember 2024 bekannt	CI

Andere Sprachen

Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025	22.04.
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024	22.04.
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Approves Board Elections	10.02.
Certain A Shares of Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. are subject to a Lock-Up Agreement Ending on 21-DEC-2024.	21.12.
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024	28.10.24
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	14.08.24
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Announces Cash Dividend for the Year 2023, Payable on 3 June 2024	27.05.24
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	22.04.24
Tranche Update on Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.'s Equity Buyback Plan announced on August 24, 2023.	21.12.23
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.'s Equity Buyback announced on August 24, 2023, has closed with 777,300 shares, representing 0.72% for CNY 49.99 million,	20.12.23
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	25.10.23
Tranche Update on Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.'s Equity Buyback Plan announced on August 24, 2023.	10.10.23
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.(XSEC:301096) added to S&P Global BMI Index	18.09.23
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. announces an Equity Buyback for CNY 50 million worth of its shares.	24.08.23
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. authorizes a Buyback Plan.	24.08.23
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	09.08.23
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	27.04.23
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Approves Cash Dividend for 2022, Payable on 04 May 2023	20.04.23
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Proposes Cash Dividend for the Year 2022	29.03.23
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	12.03.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.

Aktien

301096

CNE1000056N5

301096

Biotechnologie

Andere Sprachen

Filter